Castle Creek Biosciences Inc.

Plus: Hummingbird/Callio, Bridgene/Takeda, Magnet/Lilly, Gensaic/Novo, and more

New approaches go beyond small molecules and enzymes to bacteria, mRNA, protein and gene therapies

BioCentury’s roundup of translational news

The clinical pipeline of lentivirus-based gene therapies for rare diseases contains at least 19 programs by 10 companies

Plus BMS-Prellis, Lysogene-Sarepta, Biohaven-KU Leuven, Castle Creek-Novavita and Idorsia

Plus: BioTheryX, BioCryst, Redx, Tango, Epizyme and more

Amy Mahery, a 17-year veteran at Merck KGaA (Xetra:MRK), was named the pharma’s SVP and head of the neurology and immunology global business franchise; she was SVP and head of global market

EQRx Inc. hired Jami Rubin as CFO and Kent Rogers as chief customer officer. Rubin was partner at PJT Partners and managing director at Goldman Sachs. Rogers was SVP and chief industry relations